Andere talen Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE

Aandelen

TEVA

IL0006290147

Beurs gesloten - TEL AVIV STOCK EXCHANGE Andere beurzen 16:24:10 10-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
6.309 ^ILa	+0,22%		+0,94%	+65,37%

11/06	Transcript : Teva Pharmaceutical Industries Limited Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 08:00 AM
05/06	TEVA PHARMACEUTICAL INDUSTRIES LIMITED : Barclays herhaalt koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference	04/06
Teva Pharmaceuticals - New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY Extended-Release Injectable Suspension from Invega Sustenna	03/06
New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)	01/06
Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024	01/06
Teva Pharmaceutical Gains FDA Approval for Daily Huntington's Disease Pill	30/05
Teva Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24–48 mg/day)	30/05
Teva Pharmaceutical Industries Limited Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24?48 mg/day)	30/05
Teva and Alvotech Announce SIMLANDI Injection Now Available in the U.S.	22/05
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.	21/05
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.	21/05
Teva Pharmaceutical Industries Limited and Alvotech Announce SIMLANDI® Injection Now Available in the U.S	21/05
Teva Pharmaceutical Industries Insider Sold Shares Worth $470,794, According to a Recent SEC Filing	17/05
New EVP, Teva Global Operations appointed	16/05
Teva Pharmaceutical Industries Insider Sold Shares Worth $254,807, According to a Recent SEC Filing	15/05
Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations	15/05
Teva Pharmaceutical Industries Limited Announces Management Changes, Effective June 3, 2024	15/05
Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-749 as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia	09/05
En Direct des Marchés : Sabadell, TotalEnergies, Airbnb, ARM, Medincell, Nexi...	09/05
Teva Pharmaceutical Industries : Immediate Report	08/05
Sector Update: Health Care Stocks Slipping Wednesday Afternoon	08/05

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Headlines

Teva CEO over tweede kwartaal, mogelijke schikking met DOJ

02 augustus 2023 om 21:19 uur